Joan S. Hooper Sells 938 Shares of Itron, Inc. (NASDAQ:ITRI) Stock

Itron, Inc. (NASDAQ:ITRI - Get Free Report) CFO Joan S. Hooper sold 938 shares of the company's stock in a transaction on Tuesday, May 27th. The shares were sold at an average price of $114.95, for a total value of $107,823.10. Following the completion of the transaction, the chief financial officer now owns 89,364 shares of the company's stock, valued at $10,272,391.80. The trade was a 1.04% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link.

Itron Stock Performance

ITRI stock traded up $2.44 during midday trading on Friday, reaching $116.15. The company had a trading volume of 649,684 shares, compared to its average volume of 577,070. The firm has a market capitalization of $5.30 billion, a PE ratio of 23.80, a P/E/G ratio of 0.81 and a beta of 1.31. The stock has a 50 day moving average price of $106.85 and a 200 day moving average price of $107.70. Itron, Inc. has a fifty-two week low of $90.11 and a fifty-two week high of $124.90. The company has a quick ratio of 2.83, a current ratio of 3.36 and a debt-to-equity ratio of 0.91.

Itron (NASDAQ:ITRI - Get Free Report) last posted its earnings results on Thursday, May 1st. The scientific and technical instruments company reported $1.52 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.30 by $0.22. The company had revenue of $607.15 million for the quarter, compared to analysts' expectations of $608.86 million. Itron had a return on equity of 19.03% and a net margin of 9.37%. The firm's quarterly revenue was up .6% compared to the same quarter last year. During the same period last year, the business posted $1.24 earnings per share. Analysts anticipate that Itron, Inc. will post 5.33 earnings per share for the current year.

Wall Street Analyst Weigh In

Several brokerages recently weighed in on ITRI. Guggenheim reaffirmed a "buy" rating and issued a $133.00 target price on shares of Itron in a research report on Thursday, April 17th. Piper Sandler dropped their price objective on shares of Itron from $124.00 to $121.00 and set a "neutral" rating on the stock in a research note on Monday, May 5th. Wall Street Zen upgraded shares of Itron from a "hold" rating to a "buy" rating in a research note on Saturday, May 24th. Canaccord Genuity Group lifted their price target on shares of Itron from $130.00 to $132.00 and gave the stock a "buy" rating in a research note on Wednesday, February 26th. Finally, Oppenheimer upped their price objective on shares of Itron from $124.00 to $131.00 and gave the company an "outperform" rating in a research report on Wednesday, February 26th. Three equities research analysts have rated the stock with a hold rating and nine have given a buy rating to the company's stock. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $127.36.

Institutional Trading of Itron

Several large investors have recently added to or reduced their stakes in ITRI. Invesco Ltd. increased its holdings in shares of Itron by 2.7% during the first quarter. Invesco Ltd. now owns 2,310,769 shares of the scientific and technical instruments company's stock valued at $242,076,000 after purchasing an additional 59,962 shares during the period. Amundi increased its stake in Itron by 18.4% during the 1st quarter. Amundi now owns 929,407 shares of the scientific and technical instruments company's stock valued at $97,313,000 after buying an additional 144,361 shares during the period. First Trust Advisors LP raised its position in shares of Itron by 9.1% during the 4th quarter. First Trust Advisors LP now owns 802,584 shares of the scientific and technical instruments company's stock worth $87,145,000 after buying an additional 66,637 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its position in Itron by 129.7% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 732,274 shares of the scientific and technical instruments company's stock worth $76,713,000 after purchasing an additional 413,487 shares during the period. Finally, Norges Bank bought a new position in Itron during the fourth quarter valued at about $64,615,000. 96.19% of the stock is currently owned by institutional investors and hedge funds.

Itron Company Profile

Itron, Inc, a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing, such as standard gas, electricity, water, and communicating meters, as well as heat and allocation products.